Anistreplase

Anistreplase

Clinical data
ATC code	B01AD03 (WHO)
Identifiers
CAS Number	81669-57-0
DrugBank	BTD00102
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C2569H3928N746O781S40
Molar mass	59042.3 g/mol

WikiDoc Resources for Anistreplase
Articles
Most recent articles on Anistreplase Most cited articles on Anistreplase Review articles on Anistreplase Articles on Anistreplase in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Anistreplase Images of Anistreplase Photos of Anistreplase Podcasts & MP3s on Anistreplase Videos on Anistreplase
Evidence Based Medicine
Cochrane Collaboration on Anistreplase Bandolier on Anistreplase TRIP on Anistreplase
Clinical Trials
Ongoing Trials on Anistreplase at Clinical Trials.gov Trial results on Anistreplase Clinical Trials on Anistreplase at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Anistreplase NICE Guidance on Anistreplase NHS PRODIGY Guidance FDA on Anistreplase CDC on Anistreplase
Books
Books on Anistreplase
News
Anistreplase in the news Be alerted to news on Anistreplase News trends on Anistreplase
Commentary
Blogs on Anistreplase
Definitions
Definitions of Anistreplase
Patient Resources / Community
Patient resources on Anistreplase Discussion groups on Anistreplase Patient Handouts on Anistreplase Directions to Hospitals Treating Anistreplase Risk calculators and risk factors for Anistreplase
Healthcare Provider Resources
Symptoms of Anistreplase Causes & Risk Factors for Anistreplase Diagnostic studies for Anistreplase Treatment of Anistreplase
Continuing Medical Education (CME)
CME Programs on Anistreplase
International
Anistreplase en Espanol Anistreplase en Francais
Business
Anistreplase in the Marketplace Patents on Anistreplase
Experimental / Informatics
List of terms related to Anistreplase

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Anistreplase is a thrombolytic drug. It converts plasminogen to plasmin, which in turn degrades fibrin (blood clots) to fibrin split products.

Also known as anisoylated plasminogen streptokinase activator complex (APSAC)

Template:WikiDoc Sources